Market Place
Sourcing Support
Spectral Medical Announces Q3 Results & Provides Corporate Update
08 Nov 2024 //
GLOBENEWSWIRE
Spectral Medical Provides October Tigris Trial Update
04 Nov 2024 //
GLOBENEWSWIRE
Spectral Medical Provides September Tigris Trial Update
03 Oct 2024 //
GLOBENEWSWIRE
Spectral Medical Provides August Tigris Trial Update
03 Sep 2024 //
GLOBENEWSWIRE
Spectral Medical Announces Second Quarter Results and Provides Corporate Update
09 Aug 2024 //
GLOBENEWSWIRE
Spectral Medical Provides July Tigris Trial Update
01 Aug 2024 //
GLOBENEWSWIRE
Spectral Medical Closes Additional US$1M Convertible Notes
22 Jul 2024 //
GLOBENEWSWIRE
Spectral Medical Inc. Announces Change to Auditor
11 Jul 2024 //
GLOBENEWSWIRE
Spectral Medical Provides June Tigris Trial Update
02 Jul 2024 //
GLOBENEWSWIRE
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
07 Jun 2024 //
GLOBENEWSWIRE
Spectral Medical Closes C$8.5M Convertible Notes Financing
30 May 2024 //
GLOBENEWSWIRE
Spectral Medical Announces First Quarter Results and Provides Corporate Update
13 May 2024 //
GLOBENEWSWIRE
Spectral C$8.5M Bought Deal Convertible Note Financing
09 May 2024 //
GLOBENEWSWIRE
Spectral Medical Provides April Tigris Trial Update
06 May 2024 //
GLOBENEWSWIRE
Spectral Medical Provides Tigris Trial Update
10 Apr 2024 //
GLOBENEWSWIRE
Spectral Medical Chair to Retire From the Board of Directors
02 Apr 2024 //
GLOBENEWSWIRE
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results
28 Mar 2024 //
GLOBENEWSWIRE
Spectral Medical Provides February Tigris Trial Update
28 Feb 2024 //
GLOBENEWSWIRE
Spectral Medical Announces Extension of Distribution Agreement With Baxter
21 Feb 2024 //
GLOBENEWSWIRE
Spectral Announces Major Milestone by Reaching Its Interim Enrollment Target
15 Feb 2024 //
GLOBENEWSWIRE
Spectral Medical Provides Early February Tigris Trial Update
05 Feb 2024 //
GLOBENEWSWIRE
Spectral Medical Provides January Tigris Trial Update
30 Jan 2024 //
GLOBENEWSWIRE
Spectral Medical Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial
10 Jan 2024 //
GLOBENEWSWIRE
Spectral Medical Provides Tigris Trial Update
14 Dec 2023 //
GLOBENEWSWIRE
Spectral Medical Provides November Tigris Trial Update
04 Dec 2023 //
GLOBENEWSWIRE
Spectral Medical Announces CFO Departure
01 Dec 2023 //
GLOBENEWSWIRE
Spectral Medical Announces Publication of Tigris Trial Methods Paper of Results
14 Nov 2023 //
GLOBENEWSWIRE
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
09 Nov 2023 //
GLOBENEWSWIRE
Spectral Medical Provides Tigris Trial Update
07 Nov 2023 //
GLOBENEWSWIRE
Spectral Medical Announces Opening of Tigris Trial Site at the Mayo Clinic
16 Oct 2023 //
GLOBENEWSWIRE
Spectral Medical Provides Tigris Trial Update
03 Oct 2023 //
GLOBENEWSWIRE
Spectral Medical Provides Board Update
02 Oct 2023 //
GLOBENEWSWIRE
Spectral Medical Featured in New Episode of ˜The Balancing Act
08 Sep 2023 //
GLOBENEWSWIRE
Spectral Medical Closes C$6.1 Million Bought Deal Convertible Note Financing
07 Sep 2023 //
GLOBENEWSWIRE
Spectral Medical Highlights New Episode of ˜The Balancing Act™ Airing
16 Aug 2023 //
GLOBENEWSWIRE
Spectral Medical Announces C$5 Million Bought Deal Convertible Note Financing
10 Aug 2023 //
GLOBENEWSWIRE
Spectral Medical Announces Second Quarter Results and Provides Corporate Update
10 Aug 2023 //
GLOBENEWSWIRE
Spectral Medical Announces Tigris Clinical Trial Update
25 Jul 2023 //
GLOBENEWSWIRE
Spectral Announces the Opening of Three Additional Tigris Clinical Trial Sites
05 Jul 2023 //
GLOBENEWSWIRE
Spectral Medical Appoints Former FDA Director, Dr. David W. Feigal
27 Jun 2023 //
GLOBENEWSWIRE
Spectral Medical Provides Update on Continued Favorable Tigris Trial Enrollment
20 Jun 2023 //
GLOBENEWSWIRE
Spectral Medical Provides Update on Favorable Tigris Clinical Trial Enrollment
30 May 2023 //
GLOBENEWSWIRE
Spectral Medical Hosts Successful Investigator Meeting; Expected to Help Bolster
24 May 2023 //
GLOBENEWSWIRE
Spectral Medical Announces First Quarter Results and Provides Corporate Update
12 May 2023 //
GLOBENEWSWIRE
Spectral Medical Inc. Announces Director Resignation
04 May 2023 //
GLOBENEWSWIRE
Filing of Form S-4 and Mailing of Proxy Statement by Rosecliff Acquisition
02 May 2023 //
PHARMIWEB
Spectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial
18 Apr 2023 //
GLOBENEWSWIRE
Spectral Medical Announces Investor Update Conference Call
06 Apr 2023 //
GLOBENEWSWIRE
Spectral MD Announces U.S. Burn AI Clinical Training Study Enrollment Completion
27 Mar 2023 //
ACCESSWIRE
Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results
24 Mar 2023 //
GLOBENEWSWIRE
Spectral Announces the Opening of Two Additional Tigris Clinical Trial Sites
09 Mar 2023 //
GLOBENEWSWIRE
Spectral Medical Provides Update on Tigris Trial and Business Developments
12 Jan 2023 //
GLOBENEWSWIRE
Spectral Medical Announces Strategic Joint Venture With Infomed
13 Dec 2022 //
GLOBENEWSWIRE
Spectral Medical Inc. Closes $10.8 Million Public Offering
02 Nov 2022 //
GLOBENEWSWIRE
Spectral Medical Inc. Announces Pricing of Previously Announced Offering
06 Oct 2022 //
GLOBENEWSWIRE
Spectral Medical Inc. Announces Proposed Public Offering of Units
05 Oct 2022 //
GLOBENEWSWIRE
Spectral Medical Provides Update on Tigris Clinical Trial
04 Oct 2022 //
GLOBENEWSWIRE
Spectral Announces FDA Approval to Add Up to 10 Additional Tigris Trial Sites
18 Aug 2022 //
GLOBENEWSWIRE
Dialco Medical, Marathon Medical Awarded Contract for SAMI Dialysis Devices
08 Aug 2022 //
GLOBENEWSWIRE
Spectral Medical Provides Update on Tigris Clinical Trial
20 Jul 2022 //
GLOBENEWSWIRE
